Cindy Wong
Keine laufenden Positionen mehr
Karriereverlauf von Cindy Wong
Ehemalige bekannte Positionen von Cindy Wong
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MOBERG PHARMA AB | Technik-/Wissenschafts-/F&E-Leiter | 30.07.2020 | 01.01.2023 |
HANSA BIOPHARMA AB | Direktor/Vorstandsmitglied | 01.01.2012 | 11.05.2016 |
Independent Dir/Board Member | 01.01.2012 | 11.05.2016 | |
Merz Pharmaceuticals GmbH
Merz Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Merz Pharmaceuticals GmbH discovers and develops drugs for the treatment of neurological and psychiatric diseases. Its dermatology products focus on the treatment of scars, acne, hair loss and fungal diseases. In the area of metabolic disturbances, it offers therapies for liver disease and lipid metabolism disorders. The company also offers various OTC products, including cold remedies, skin care products and vitamin supplements under the brand names tetesept and Merz Special. The company is headquartered in Frankfurt am Main, Germany. | Corporate Officer/Principal | - | - |
ONCOZENGE AB | Vertrieb & Marketing | 01.01.2020 | - |
Q-Med AB
Q-Med AB Medical SpecialtiesHealth Technology Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Cindy Wong
University of Adelaide | Doctorate Degree |
Statistik
International
Schweden | 4 |
Australien | 2 |
Vereinigte Staaten | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 2 |
Director/Board Member | 1 |
Independent Dir/Board Member | 1 |
Sektoral
Health Technology | 6 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
HANSA BIOPHARMA AB | Health Technology |
MOBERG PHARMA AB | Health Technology |
ONCOZENGE AB | Health Technology |
Private Unternehmen | 2 |
---|---|
Q-Med AB
Q-Med AB Medical SpecialtiesHealth Technology Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden. | Health Technology |
Merz Pharmaceuticals GmbH
Merz Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Merz Pharmaceuticals GmbH discovers and develops drugs for the treatment of neurological and psychiatric diseases. Its dermatology products focus on the treatment of scars, acne, hair loss and fungal diseases. In the area of metabolic disturbances, it offers therapies for liver disease and lipid metabolism disorders. The company also offers various OTC products, including cold remedies, skin care products and vitamin supplements under the brand names tetesept and Merz Special. The company is headquartered in Frankfurt am Main, Germany. | Health Technology |
- Börse
- Insiders
- Cindy Wong
- Erfahrung